Varex Imaging (NASDAQ:VREX) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen lowered shares of Varex Imaging (NASDAQ:VREX) from a buy rating to a hold rating in a report released on Saturday morning.

Other research analysts have also issued research reports about the stock. Jefferies Financial Group reaffirmed a “hold” rating and issued a $14.50 price target on shares of Varex Imaging in a research note on Monday, February 2nd. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. Finally, Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.17.

Varex Imaging Stock Performance

Shares of VREX opened at $9.83 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.87 and a current ratio of 3.89. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $14.56. The firm’s 50 day moving average price is $11.55 and its two-hundred day moving average price is $12.17. The firm has a market cap of $411.88 million, a P/E ratio of -4.92 and a beta of 0.96.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.21%. The company had revenue of $216.00 million during the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. On average, analysts forecast that Varex Imaging will post 0.93 EPS for the current fiscal year.

Insider Activity at Varex Imaging

In other news, Director Jay K. Kunkel sold 4,510 shares of the business’s stock in a transaction on Friday, March 20th. The shares were sold at an average price of $11.14, for a total value of $50,241.40. Following the sale, the director owned 23,450 shares of the company’s stock, valued at $261,233. The trade was a 16.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 4.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Varex Imaging

Institutional investors have recently made changes to their positions in the business. State of Alaska Department of Revenue bought a new stake in shares of Varex Imaging in the third quarter worth $27,000. Rockefeller Capital Management L.P. bought a new stake in shares of Varex Imaging in the fourth quarter worth $27,000. Quarry LP bought a new stake in shares of Varex Imaging in the third quarter worth $64,000. Aquatic Capital Management LLC bought a new stake in shares of Varex Imaging in the third quarter worth $117,000. Finally, Legato Capital Management LLC bought a new stake in shares of Varex Imaging in the third quarter worth $125,000.

Varex Imaging News Roundup

Here are the key news stories impacting Varex Imaging this week:

• Neutral Sentiment: Varex reported Q2 revenue of $216 million and adjusted EPS of $0.21, both just below consensus, while the company said demand remained solid and margins held relatively steady. Varex Announces Financial Results for Second Quarter Fiscal Year 2026
• Neutral Sentiment: The company’s GAAP results were weaker, with a net loss of $0.19 per diluted share and $2 million in cash outflows from operations, which may keep some pressure on the stock despite stable gross margins. Varex Announces Financial Results for Second Quarter Fiscal Year 2026
• Negative Sentiment: Varex’s Q3 fiscal 2026 guidance called for EPS of $0.15 to $0.30 versus analysts’ $0.22 estimate, and revenue guidance of $210 million to $225 million versus about $215.5 million expected, signaling only modest upside and likely disappointing investors looking for a stronger outlook. Varex Announces Financial Results for Second Quarter Fiscal Year 2026
• Negative Sentiment: Coverage from earnings transcript and analysis pieces on Yahoo Finance, Seeking Alpha, and Zacks all centered on the earnings and revenue miss, reinforcing the market’s negative reaction to the quarterly update. Varex Imaging (VREX) Q2 2026 Earnings Transcript

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.